A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin
Condition(s):Solid TumorsLast Updated:April 3, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Solid TumorsLast Updated:April 3, 2020Completed
Condition(s):InfectionLast Updated:September 14, 2012Terminated
Condition(s):Drug Interactions; PharmacokineticsLast Updated:December 12, 2016Completed
Condition(s):Drug-drug InteractionLast Updated:September 8, 2021Completed
Condition(s):TuberculosisLast Updated:March 23, 2023Completed
Condition(s):Contraception; TuberculosisLast Updated:May 16, 2023Completed
Condition(s):Healthy ParticipantsLast Updated:March 2, 2022Withdrawn
Condition(s):Idiopathic Infantile Hypercalcemia – Mild FormLast Updated:August 31, 2021Unknown status
Condition(s):HealthyLast Updated:May 5, 2016Completed
Condition(s):TuberculosisLast Updated:November 20, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.